INTERPACE BIOSCIENCES, INC（IDXG）美股招股说明书 S-1 （2022-01-07修订版）（英文版）（156页）.pdf

1、 As filed with the Securities and Exchange Commission on January 7,2022Registration No.333-261504 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 Amendment No.2toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 INTERPACE BIOSCIENCES,INC.(Exact name of registrant as s

2、pecified in its charter)Delaware 3841 22-2919486(State or other jurisdictionof incorporation)(Primary Standard IndustrialClassification Code Number)(IRS EmployerIdentification No.)Morris Corporate Center 1,Building C300 Interpace ParkwayParsippany,New Jersey 07054(855)776-6419(Address,including zip

3、code,and telephone number,including area code,of registrants principal executive offices)Thomas W.BurnellPresident,Chief Executive Officer and DirectorMorris Corporate Center 1,Building C300 Interpace ParkwayParsippany,New Jersey 07054(855)776-6419(Name,address,including zip code,and telephone numbe

4、r,including area code,of agent for service)Copies to:Merrill M.Kraines,Esq.Troutman Pepper Hamilton Sanders LLP875 Third AvenueNew York,NY 10022Tel:(212)808-2711 Approximate date of commencement of proposed sale to the public:As soon as practicable after this Registration Statementbecomes effective.

5、If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities A

6、ct,check thefollowing box and list the Securities Act registration statement number of the earlier effective registration statement for the same2025/9/12 08:57sec.gov/Archives/edgar/data/1054102/000149315222000718/forms-1a.htmhttps:/www.sec.gov/Archives/edgar/data/1054102/000149315222000718/forms-1a